Literature DB >> 29053890

Prospective comparison of acute motor axonal neuropathy and acute inflammatory demyelinating polyradiculoneuropathy in 140 children with Guillain-Barré syndrome in India.

Jayantee Kalita1, Mritunjai Kumar1, Usha K Misra1.   

Abstract

INTRODUCTION: There have been few reports on subtypes of Guillain-Barré syndrome (GBS) in children. We compared clinical and laboratory findings of acute inflammatory demyelinating polyradiculoneuropathy (AIDP) and acute motor axonal neuropathy (AMAN).
METHODS: One hundred forty children with GBS were included. Based on nerve conduction study (NCS) findings, patients were subclassified as AIDP, AMAN, acute motor sensory axonal neuropathy (AMSAN), and equivocal.
RESULTS: Clinically, 72.1% of patients had pure motor, 24.3% motor sensory, and 3.4% Miller Fisher syndrome. Based on NCS, 67.8% of patients had AIDP, 23.6% had AMAN, and 4.3% had AMSAN. By 3 months, 2.1% patients had died, 47.1% had complete recovery, and 24.3% had poor recovery (wheelchair-bound). Children with AMAN had more frequent lower limb weakness (P = 0.02) and a lower probability of complete recovery (P = 0.01) at 3 months than children with AIDP (56% vs. 30%). DISCUSSION: AIDP is the most common GBS subtype in children. It is characterized by better recovery at 3 months when compared with AMAN. Muscle Nerve 57: 761-765, 2018.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  AIDP; AMAN; Guillain-Barré syndrome; children; outcome; pediatric

Mesh:

Year:  2017        PMID: 29053890     DOI: 10.1002/mus.25992

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  7 in total

Review 1.  How Important it is to Differentiate AMAN from AIDP in Childhood GBS? A Clinician's Perspective.

Authors:  Juhi Gupta; Prashant Jauhari
Journal:  Indian J Pediatr       Date:  2019-03-07       Impact factor: 1.967

2.  Successful treatment of a 12-year-old boy with Guillain-Barré syndrome requiring tracheostomy due to respiratory muscle paralysis: A case report.

Authors:  Manabu Miyamoto; George Imataka; Go Ichikawa; Yutaka Saito; Takashi Kashiwagi; Yoshiyuki Kaji; Koji Wake; Kei Funakoshi; Takahide Nagashima; Norito Kokubun; Shigemi Yoshihara
Journal:  Exp Ther Med       Date:  2019-12-10       Impact factor: 2.447

3.  How Different is AMAN from AIDP in Childhood GBS? A Prospective Study from North India.

Authors:  Pradeep Kumar Gupta; Pratibha Singhi; Sunit Singhi; Ananthanarayanan Kasinathan; Naveen Sankhyan
Journal:  Indian J Pediatr       Date:  2019-01-12       Impact factor: 1.967

4.  Modified Zipper Method, a Promising Treatment Option in Severe Pediatric Immune-Mediated Neurologic Disorders.

Authors:  Marc Nikolaus; Fabienne Kühne; Anna Tietze; Julia Thumfart; Caroline Kempf; Alexander Gratopp; Ellen Knierim; Petra Bittigau; Angela M Kaindl
Journal:  J Child Neurol       Date:  2022-04-18       Impact factor: 2.363

5.  Prevalence and outcomes of Guillain-Barré syndrome among pediatrics in Saudi Arabia: a 10-year retrospective study.

Authors:  Safiyyah Asiri; Waleed A Altwaijri; Duaa Ba-Armah; Ahmed Al Rumayyan; Muhammad T Alrifai; Mahmoud Salam; Adel F Almutairi
Journal:  Neuropsychiatr Dis Treat       Date:  2019-03-01       Impact factor: 2.570

6.  Clinical profile and predictors for outcome in children presenting with Guillain-Barré syndrome.

Authors:  Sonali Singh; Nitin Gupta; Arpita M Gupta; Anurag S Chandel; Sneha Waghela; Pallavi Saple
Journal:  J Family Med Prim Care       Date:  2020-10-30

7.  Impact of the COVID-19 Pandemic on the Frequency, Clinical Spectrum and Outcomes of Pediatric Guillain-Barré Syndrome in India: A Multicentric Ambispective Cohort Study.

Authors:  Divyani Garg; Rajinder K Dhamija; Aditya Choudhary; Ritu Shree; Sujit Kumar; Priyanka Samal; Abhishek Pathak; Pamidimukkala Vijaya; Yareeda Sireesha; Sruthi S Nair; Sanjay Sharma; Soaham Desai; Human P Sinha; Ayush Agarwal; Ashish Upadhyay; M V Padma Srivastava; Rohit Bhatia; Awadh K Pandit; Rajesh K Singh; Alisha Reyaz; P M Yogeesh; Manish Salunkhe; Vivek Lal; Manish Modi; Gagandeep Singh; Monika Singla; Samhita Panda; Maya Gopalakrishnan; Inder Puri; Sudhir Sharma; Bismay Kumar; Prashant K Kushwaha; Harshadkumar Chovatiya; Teresa Ferreira; Sanjeev K Bhoi; Manish Bhartiya; Subhash Kaul; Anuja Patil; Neeharika L Mathukumalli; Madhu Nagappa; P Praveen Sharma; Aneesh Basheer; Dileep Ramachandran; Neetha Balaram; Jospeh Sebastian; Venugopalan Y Vishnu
Journal:  Ann Indian Acad Neurol       Date:  2021-11-17       Impact factor: 1.383

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.